Diabetic nephropathy--where next?
Phillips
A O
AO
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000818:Animals; D016207:Cytokines / Q000378:metabolism; D003928:Diabetic Nephropathies / Q000209:etiology / Q000378:metabolism / Q000628:therapy*; D006801:Humans; D006943:Hyperglycemia / Q000150:complications; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D007676:Kidney Failure, Chronic / Q000209:etiology; D017410:Practice Guidelines as Topic; D011945:Receptors, Angiotensin / Q000627:therapeutic use; D012017:Referral and Consultation; D012377:Rodentia
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D016207:Cytokines; D011945:Receptors, Angiotensin